Take what to save endangered cheap medicine

08:36 on October 19, 2016

Source: Beijing morning post

Lower-priced medicine adequate market supply, it is a major part of the authorities. Otherwise, the price policy fell less than substance, people won't get affordable, so that ordinary people rather than feel policy of goodwill, will only increase the inconvenience.

In recent years, cheap but effective and cheap medicine is difficult to be replaced are slowly disappearing from the market. Under the condition of a medicine is hard to find, cattle as a speculation business. Recent media reports, a box of injection for the treatment of rare infant spasm with corticotrophin (ACTH) normal retail price 7.8 yuan, but is difficult to find in many hospitals, and on the "black market" price has more than 4000 yuan, even this "day price", due to the scarcity of drugs is still not easy to buy. (on October 18, the science and technology journal)

As reported, corticotrophin belong to the category of common low medicine, according to the general law of the market, some get the welcome of consumer goods, best-selling in the market, enterprises should be a large number of production, business should be a large number of replenish onr's stock, in order to meet the demand of consumer is. But why specific to the medicine, the law is no longer applicable?

Squalor, low-priced medicine playing "disappeared", the fundamental problem in a word. Pharmaceutical factory no profit or cheap, no production power, low medicine source; Druggist unprofitable or cheap, not willing to run, low medicine can't flow; Hospitals and doctors and pharmacies unprofitable or cheap, cheap drugs into the hospital or the doctor is not cheap medicine, the drug into low price; Supply, three control drug market main body resist cheap drugs, low-cost medicine to living space?

So, keep a low price, let people pay less, relevant government departments must suit the remedy to the case. First, you can establish compensation mechanism, through tax breaks, such as increase subsidies for drug firms lose out, some encourage drug companies to produce cheap medicine. Second, in the basic policy, drug centralized bid procurement can consider the price factor, appropriately expand drug firms competition, ensuring the supply of cheap medicine market, rather than blindly to drug companies to reduce the price, eventually vanish and fishing. Moreover, quota preferred to try, to ensure that drug companies and pharmacy, the minimum supply cheap drugs each year, security market is available.

All in all, lower-priced medicine adequate market supply, it is a major part of the authorities. Otherwise, the price policy fell less than substance, people won't get affordable, so that ordinary people rather than feel policy of goodwill, will only increase the inconvenience. (reporter He Xu)